Scholarlink

Background and aims <p>Mitochondrial GTPase ERA G-protein-like 1 (ERAL1) is considered an antiviral host factor against RNA viruses. However, its role in driving DNA virus infection, particularly hepatitis B virus (HBV) infection, and its relevance to human liver disease are unknown. This study aimed to define the function and molecular mechanism of ERAL1 in HBV pathogenesis.</p> Methods <p>Complementary models, including HBV-replicating cell lines, an rAAV8-HBV hydrodynamic mouse model, and clinical samples from patients across the natural history of chronic HBV infection were employed and analyzed via coimmunoprecipitation, confocal immunofluorescence, RNA sequencing, qPCR, immunoblotting, and immunohistochemistry.</p> Results <p>ERAL1 expression was significantly suppressed in HBV patients, including an approximately 75% reduction in the livers of patients during the immune-reactive phase compared with those in healthy controls. ERAL1 overexpression resulted in notable antiviral activity, suppressed HBV replication and achieved nearly 60% HBsAg clearance in vivo. Mechanistically, ERAL1 interacts with mitochondrial adaptor MAVS, promoting its aggregation and subsequently activating the downstream Akt and MAPK signaling pathways, which are essential for its antiviral effect.</p> Conclusions <p>ERAL1 is identified as a crucial HBV-restricting host factor and a novel mitochondria-centered defense mechanism in which ERAL1 reinforces MAVS-dependent antiviral signaling. The notable downregulation of ERAL1 in patient livers and its considerable antiviral effectiveness suggest that ERAL1 is a candidate host factor worthy of further therapeutic exploration.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

The mitochondrial GTPase ERAL1 inhibits HBV replication by triggering the MAVS signaling cascade

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年6月16日

查看全文
  • Caorui Lin,
  • Xiaosang Zheng,
  • Kaixin Chen,
  • Ning Ran,
  • Linjie Luo,
  • Xin Zhang,
  • Ying Huang,
  • Jiawei Zhang,
  • Hanyong Zhu,
  • Jieying He,
  • Bin Yang,
  • Qishui Ou,
  • Can Liu

摘要

Background and aims

Mitochondrial GTPase ERA G-protein-like 1 (ERAL1) is considered an antiviral host factor against RNA viruses. However, its role in driving DNA virus infection, particularly hepatitis B virus (HBV) infection, and its relevance to human liver disease are unknown. This study aimed to define the function and molecular mechanism of ERAL1 in HBV pathogenesis.

Methods

Complementary models, including HBV-replicating cell lines, an rAAV8-HBV hydrodynamic mouse model, and clinical samples from patients across the natural history of chronic HBV infection were employed and analyzed via coimmunoprecipitation, confocal immunofluorescence, RNA sequencing, qPCR, immunoblotting, and immunohistochemistry.

Results

ERAL1 expression was significantly suppressed in HBV patients, including an approximately 75% reduction in the livers of patients during the immune-reactive phase compared with those in healthy controls. ERAL1 overexpression resulted in notable antiviral activity, suppressed HBV replication and achieved nearly 60% HBsAg clearance in vivo. Mechanistically, ERAL1 interacts with mitochondrial adaptor MAVS, promoting its aggregation and subsequently activating the downstream Akt and MAPK signaling pathways, which are essential for its antiviral effect.

Conclusions

ERAL1 is identified as a crucial HBV-restricting host factor and a novel mitochondria-centered defense mechanism in which ERAL1 reinforces MAVS-dependent antiviral signaling. The notable downregulation of ERAL1 in patient livers and its considerable antiviral effectiveness suggest that ERAL1 is a candidate host factor worthy of further therapeutic exploration.